Tomivosertib in Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT05744739 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

PROCEDURE: Biospecimen Collection
DRUG: Tomivosertib

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]